Introduction {#sec1-1}
============

According to the Global Initiative for Asthma 2019 Report (GINA 2019), asthma is defined as a "heterogeneous disease characterized by chronic airway inflammation" \[[@ref1]\]. In addition, this illness is typified by "the history of respiratory symptoms such as wheeze, shortness of breath, chest tightness and cough that vary over time and in intensity together with variable expiratory air flow limitation" \[[@ref1]\]. Currently, there are around 339 million people in the world affected by this heterogeneous respiratory disease \[[@ref2]\].

To manage this illness, in addition to conventional treatments, new alternatives based on the so-called m-health technologies which use communications, information, and mobile technologies advancements, have been implemented in order to provide medical care remotely \[[@ref3]\]. Some of these alternatives employ software applications developed specifically for use on small, wireless computing devices, such as smartphones and tablets, rather than desktop or laptop computers \[[@ref4]\].

In relation to asthma, a recent study identified 523 applications available in the Apple app store and Google Play store \[[@ref5]\]. Most of these applications have been developed in the United States (37%), Switzerland (11%), Spain (5%), India (5%), Australia (5%), the United Kingdom (5%), Germany (3%), Portugal (3%), the Czech Republic (3%), Lithuania (3%), Latvia (3%) and other countries (17%) \[[@ref5]\]. The largest proportion of these applications have been developed by private companies and independent developers; and the rest by organizations related to healthcare, university hospitals, non-profit organizations and government entities \[[@ref5]\]. According to some authors, several of these applications are suitable for asthma self-management, but most of them are of low quality and are not based on medical and clinical guidelines \[[@ref5]\]. Similarly, other studies have suggested that these technologies are effective in helping the management and treatment of asthma \[[@ref6]\]. For example, one study reported that a smartphone app used continuously for 4 months was effective in improving asthma control in a group of 60 adult patients \[[@ref7]\]. Another study showed that the use of a smartphone application contributed to improve the control of asthma in a group of adolescents with persistent asthma \[[@ref9]\].

As for Saudi Arabia, statistics indicated that there is a high prevalence of asthma in adults, which is higher than most of the countries reported in the European Community Respiratory Health Survey (ECRHS), and in general its incidence in the Kingdom varies between 15-25% per region \[[@ref12],[@ref13]\]. Perceptibly, this high percentage of patients has to be followed through the use of smartphone applications and social media tools that can contribute to improve asthma management and reduce the number of affected cases and side effects through awareness and direct communication. Parallel to this situation, Saudi Arabia with an estimated population of more than 33 million, has the highest penetration rate of smartphones in the region, and by 2018 the number of smartphone users was about 22 million \[[@ref14]\]. Despite the high prevalence of asthma in the Kingdom of Saudi Arabia and the impressive use of smartphones in the region, the review of the literature showed that no mobile application for the treatment of asthma had been developed in the Kingdom.

For these reasons, the purpose of this paper is to design a smartphone application for the treatment of asthma based on the medical opinions of a group of healthcare providers from the Kingdom of Saudi Arabia.

Methods {#sec1-2}
=======

Study settings and participants {#sec2-1}
-------------------------------

To carry out this study, we used a purposive sampling method and selected a sample of young healthcare providers easily accessible and specialized in respiratory diseases in the Kingdom of Saudi Arabia. According to some studies, young doctors are the ones who use smartphone applications most frequently in their professional practices \[[@ref17],[@ref18]\]. In our case, the sample of selected young doctors also had good knowledge about the characteristics of asthma disease due to their specialization. In other words, these surveyed doctors are the ones who can give us the most appropriate and convincing opinion about the design of a smartphone application for asthma treatment in Saudi Arabia. For this reason, other respondents with a wider age range and professional experience were not considered. Then, we sent to all healthcare providers chosen in the Kingdom of Saudi Arabia a cross sectional survey questionnaire which was prepared by the research group. The questionnaire was distributed through the QuestionPro.com website. Also, hardcopies were circulated to 3 different sectors in the eastern region of this country (King Fahd University Hospital, King Fahad Specialist Hospital at Dammam, and Prince Sultan Military College of Health Sciences). Alike, the direct link for the questionnaire was distributed throughout WhatsApp and other smartphone applications. The survey was distributed among 376 selected healthcare providers, but only 94 of them (25%) responded to the survey. The data was collected between January and February 2018.

The completion of the questionnaire was considered to imply informed consent to participate in the study, and the ethical approval was obtained from the Institutional Review Board of the Imam Abdulrahman Bin Faisal University.

Description of the questionnaire {#sec2-2}
--------------------------------

The survey questionnaire had 2 parts and contained some "yes" or "no" questions, and several questions directed to assess the level of importance expressed in terms of the following scale: "not important", "somewhat important", "important" and "very important".

The first part consisted of a set of questions about the demographic information of the participants: gender, age, and years of experience, profession and work department. The second part contained several questions aimed at obtaining information about asthma and its treatment: 1) Do you deal with asthmatic patients?; 2) Do you think mobile health is a complement to the traditional treatment?; 3) Do you support the idea of using smartphone application for patients with asthma during the period of their treatment?; 4) How do you evaluate patients' use of these features: patients profile (patients diagnosis, primary physicians information, satisfaction with the treatment process); push notifications (reminders about the time to take drugs, existence of a weekly or monthly memorandum of treatment with inhalers and other drugs, reminders of clinic appointments and therapy sessions, ask for help notification sending SMS to primary physician about patient's current crisis); disease awareness (pathophysiology of disease, drug guidelines and instructions, drugs side effects, asthma triggers, references such as GINA and SINA); records (data synchronizing with healthcare providers and hospital, medication statistics, number of attacks, visual inputs such as table for peak flow/patient's reading); 5) Why don't you support the idea of using smartphone application for patients with asthma during the period of their treatment?

Statistical analysis {#sec2-3}
--------------------

The data were expressed in terms of percentages using basic descriptive statistics.

Results {#sec1-3}
=======

The demographic information of the respondents of this study is shown in [Table 1](#table001){ref-type="table"}. In this table we can observe that more than half of the participants (56%) were males and the majority of them (96%) were under 40 years old. In addition, the majority of the respondents (90%) were respiratory therapists, and 87% of the participants were working in respiratory hospital departments.

Also, in [Figure 1](#fig001){ref-type="fig"}, we can appreciate that most of the respondents (96%) thought that mobile health is a complement to the traditional treatment processes for the purpose of providing medical care remotely. Similarly, according to [Figure 2](#fig002){ref-type="fig"}, the majority of the participants (87%) agreed that mobile treatment is an important part of asthma patients' care.

In [Table 2](#table002){ref-type="table"} is presented the evaluation of some features of the patients' profile to be included in the design of a smartphone application for asthma. The data indicated that most of the respondents (98%) supported the idea that information about patient diagnosis was important or very important to be incorporated in the design of the app. Similarly, the majority of the participants (91%) believed that patient satisfaction with the therapeutic process, and primary physician accesses (83%) were also important or very important. Alike, in [Table 3](#table003){ref-type="table"} are described the responses on push notifications in the mobile app. The data showed that 95% of participants suggested that push notifications about reminder for drugs were important or very important. Likewise, 92% of the respondents were in favor of having push notification for the existence of a weekly or monthly memorandum of the treatment with inhaler and other drugs. In the same way, 81 % of the respondents considered that having push notifications about reminders of clinic visits and therapy sections were important or very important, and 89% of them wanted to ask for help sending SMS to primary physician about patients' current crisis.

In [Table 4](#table004){ref-type="table"}, we observed that the majority of respondents believed that information related to the disease awareness such as asthma triggers, drug guidelines and drug side effects was important or very o important to include in the design of the mobile application. In addition, in [Table 5](#table005){ref-type="table"} are illustrated the responses about what data should be needed/recorded for asthma care through the mobile app. The participants believed that the number of asthma attacks is the most important one (98%) followed by visual inputs about asthma (91%). As shown in [Figure 3](#fig003){ref-type="fig"}, overall, 92% of the participants considered that an asthma application designed using the guidelines of this study would really help for better asthma care.

Discussion {#sec1-4}
==========

In this study, we have proposed the design of an application for the treatment of asthma considering the opinions of a group of healthcare providers from the Kingdom of Saudi Arabia with experience in the management of this disease. It is pertinent to comment that the suggested design is based on accepted clinical and medical practice and on the information and treatment guidelines for this disease; in addition it is the first formal application prepared by our faculty members based on similar research. In this regard, some studies have considered that an asthma application design should be constructed on the opinions of health providers and researchers from universities and hospitals to avoid the limitations of several applications available in the market which are of low quality and have been designed without support or accepted clinical and medical practice and procedures \[[@ref4],[@ref5],[@ref19]\].

![Opinion of respondents about the use of mobile health as a complement to traditional treatment (n=94).](mrm-15-1-508-g001){#fig001}

###### 

Demographic information (n=94).

                          n    \%
  ----------------------- ---- ----
  Gender                       
      Male                53   56
      Female              41   44
  Age                          
      20-39               32   35
      30-39               54   59
      40-49               8    6
  Profession                    
      Asthma education    2    1
      Nurse               3    4
      Physician           5    5
  Therapist               84   90
  Hospital department          
      Internal medicine   1    1
      Medicine            2    2
      Respiratory         79   87
      Other               12   10

###### 

Evaluation of patients' profile features to be included in the app design (n=94).

                                              Not important (%)   Somewhat important (%)   Important (%)   Very important (%)
  ------------------------------------------- ------------------- ------------------------ --------------- --------------------
  Patients diagnosis                          0                   2                        25              73
  Primary physician information               6                   11                       47              36
  Satisfaction with the therapeutic process   1                   8                        42              49

![Opinion of respondents about using mobile treatment in asthma patients' care.](mrm-15-1-508-g002){#fig002}

![Opinion of respondents about the usefulness of the designed smartphone application for asthma treatment (n=94).](mrm-15-1-508-g003){#fig003}

###### 

Evaluation of push notifications (n=94).

                                                 Not important (%)   Somewhat important (%)   Important (%)   Very important (%)
  ---------------------------------------------- ------------------- ------------------------ --------------- --------------------
  Reminders for drugs                            4                   1                        23              72
  Memorandum of treatment of inhaler and drugs   0                   8                        37              35
  Reminder of clinic and therapeutic sessions    1                   18                       31              50
  Ask for help notification                      0                   11                       41              48

###### 

Evaluation of features related to asthma awareness (n=94)

                               Not important (%)   Somewhat important (%)   Important (%)   Very important (%)
  ---------------------------- ------------------- ------------------------ --------------- --------------------
  Pathophysiology of disease   5                   13                       51              31
  Drugs guidelines             0                   6                        36              58
  Drugs side effects           0                   7                        29              64
  Asthma triggers              1                   1                        27              71
  References such as GINA      12                  16                       45              27

###### 

Evaluation of information that should be recorded on the asthma app (n=94).

                                                                   Not important (%)   Somewhat important (%)   Important (%)   Very important (%)
  ---------------------------------------------------------------- ------------------- ------------------------ --------------- --------------------
  Synchronizing with healthcare providers and healthcare centers   2                   16                       45              37
  Medication statistics                                            1                   13                       33              53
  Number of asthma attacks                                         0                   2                        40              58
  Visual notifications such as peak flow                           1                   8                        40              51

According to the opinions of the majority of health providers surveyed in this study, in the design of a useful application for the treatment of patients with asthma it is important or very important to incorporate in the application the following features:

1.  Information to increase awareness about the disease, such as asthma triggers, instructions on medications, side effects of medications, among other aspects.

2.  Information about the patient's profile (patient diagnosis, primary physician attention, and satisfaction with the therapeutic process).

3.  Push notifications that alert the patients (reminder for drugs, inhaler, clinic visits, therapy sections), and the responsible doctor or respiratory therapist.

4.  To connect (link) the patient directly with his/her healthcare provider(s).

5.  To connect (link) the patient with the database in the hospital where he/she receives treatment.

6.  To provide the patient with direct steps for treatment in case of an asthma attack until he/she arrives at the hospital or the nearest healthcare center.

7.  To provide the patient and the doctor with a timeline (graphics, peak flow) of the number of attacks, the type of medication taken, the time of occurrence of the asthma attack, the activity of the patient before an attack, *etc*.

It is pertinent to comment that several asthma applications available in the world used some of the characteristics detected in our research, for example, the symptoms of asthma, the recognition of triggers, the medication reminder, the respiration measurements, the peak flow and education about asthma \[[@ref5],[@ref19]\]. However, other features proposed in our design, such as connecting patients directly with their healthcare provider, linking patients to the database of the hospital where they receive treatment, or providing patients with direct steps for treatment in case of an asthma attack until they reach the nearest hospital or health care center, were not observed in existing applications in the market. According to most respondents, the use of an application for asthma with the above distinguishing features would be useful for the treatment of patients with asthma in Saudi Arabia.

The main limitations of this study were the small size of the healthcare providers' sample, and the statistical analysis based only in percentages. Another limitation of this research was that the inferences of the survey are not general and are restricted to the group of the selected participants that responded to the questionnaire. Future work will be directed to overcome these limitations and to target the patients themselves, and then, to link them to the Ministry of Health database in such a way that this model could be a reference throughout the Kingdom of Saudi Arabia, and worldwide in advanced stages. Also, we will investigate, whether the data and conclusions obtained in this research can be extended to the general physician population and if there are differences between the answers of the respiratory therapists' specialists against those of general physicians. In addition, the validation of the App based on asthma clinical trial will be carried out.

Conclusion {#sec1-5}
==========

In this research, we have suggested the design of a smartphone application for asthma that, according to the opinion of the majority of healthcare providers surveyed (92%), will contribute to improve the treatment of patients with asthma in the Kingdom of Saudi Arabia.

The proposed application based on medical and clinical guidelines allows automatic notifications about medication reminders, clinical visits and therapies; automatic notifications about the weekly or monthly memorandum of treatment with inhaler and other drugs; exhibits information related to the awareness of the disease such as asthma triggers, pharmacological guidelines, side effects of medications and pathophysiology of the disease; presents and transmits in real time data and visual inputs on the history of the number of asthma attacks, peak flow, and medicine statistics; sends SMS to primary physician about patients' current crisis; provides the patient with direct steps for treatment in case of an asthma attack until arrives at the hospital or the nearest healthcare center; delivers useful documentation in real time so that the attending physician knows the patient's condition and can adopt personalized measures appropriate to his/her history and treatment; additionally, allows synchronization with healthcare providers and health centers.

It can be inferred than an App designed with above features could help to decrease the number of cases that need hospitalization, and the number of asthma cases in the emergency departments in the hospitals of the Kingdom. This possibility has a positive impact on public health because it contributes to improve the quality of life of patients, and reduce the costs of treating the disease for both patients and healthcare systems.

GINA

:   Global Initiative for Asthma

ECRHS

:   European Community Respiratory Health Survey.
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